GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Luoxin Pharmaceuticals Group Stock Co Ltd (SZSE:002793) » Definitions » Cyclically Adjusted Book per Share

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Cyclically Adjusted Book per Share : ¥3.12 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Luoxin Pharmaceuticals Group Stock Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Luoxin Pharmaceuticals Group Stock Co's adjusted book value per share for the three months ended in Mar. 2024 was ¥2.147. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥3.12 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-06-15), Luoxin Pharmaceuticals Group Stock Co's current stock price is ¥4.26. Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ¥3.12. Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted PB Ratio of today is 1.37.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Luoxin Pharmaceuticals Group Stock Co was 1.69. The lowest was 1.26. And the median was 1.49.


Luoxin Pharmaceuticals Group Stock Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luoxin Pharmaceuticals Group Stock Co Cyclically Adjusted Book per Share Chart

Luoxin Pharmaceuticals Group Stock Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 3.08

Luoxin Pharmaceuticals Group Stock Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 3.08 3.12

Competitive Comparison of Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted PB Ratio falls into.



Luoxin Pharmaceuticals Group Stock Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Luoxin Pharmaceuticals Group Stock Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.147/115.2271*115.2271
=2.147

Current CPI (Mar. 2024) = 115.2271.

Luoxin Pharmaceuticals Group Stock Co Quarterly Data

Book Value per Share CPI Adj_Book
201212 0.806 95.237 0.975
201312 0.986 97.624 1.164
201412 1.237 99.000 1.440
201503 0.000 99.900 0.000
201506 0.000 99.500 0.000
201509 0.000 100.500 0.000
201512 1.331 100.600 1.525
201603 1.044 102.200 1.177
201606 1.913 101.400 2.174
201609 1.980 102.400 2.228
201612 2.054 102.600 2.307
201703 2.126 103.200 2.374
201706 2.069 103.100 2.312
201709 2.151 104.100 2.381
201712 2.218 104.500 2.446
201803 2.219 105.300 2.428
201806 2.317 104.900 2.545
201809 2.572 106.600 2.780
201812 8.782 106.500 9.502
201903 2.561 107.700 2.740
201906 2.726 107.700 2.917
201909 2.774 109.800 2.911
201912 10.228 111.200 10.598
202003 10.405 112.300 10.676
202006 2.690 110.400 2.808
202009 2.780 111.700 2.868
202012 2.755 111.500 2.847
202103 2.866 112.662 2.931
202106 2.959 111.769 3.051
202109 3.023 112.215 3.104
202112 2.996 113.108 3.052
202203 3.047 114.335 3.071
202206 2.924 114.558 2.941
202209 3.591 115.339 3.588
202212 2.919 115.116 2.922
202303 2.832 115.116 2.835
202306 2.814 114.558 2.830
202309 2.713 115.339 2.710
202312 2.271 114.781 2.280
202403 2.147 115.227 2.147

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Luoxin Pharmaceuticals Group Stock Co  (SZSE:002793) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4.26/3.12
=1.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Luoxin Pharmaceuticals Group Stock Co was 1.69. The lowest was 1.26. And the median was 1.49.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Luoxin Pharmaceuticals Group Stock Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Business Description

Traded in Other Exchanges
N/A
Address
85 Faraday Road, Floor 1-3, Building 1, Building 2, Pilot Free Trade Zone, Shanghai, CHN, 201203
Luoxin Pharmaceuticals Group Stock Co Ltd is a pharmaceutical enterprise engaged in research and development, production, and trade of new drugs. It manufactures drugs for various diseases including tumor, respiratory, gastrointestinal, endocrine, cardiovascular, nervous system, antimicrobial infection, among others.
Executives
Ye Bang Mi Supervisors
Fang Xiu Bao Directors, executives
Zhu Fu Lin Directors, executives
Chen Li Supervisors
Yao Liang Directors, executives

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Headlines

No Headlines